Home 2018-10-17T15:22:12+00:00

Surviving Disruption: Rethinking Business Models,
Technologies, and Competitive Strategies in a
Changing Lab Market

October 24-26, 2018
Save The Date!
Register this week and save up to $600

Register Now

Here are 6 reasons you need to register NOW for Lab Institute 2018 — You can’t afford to miss these 6 sessions:

John Carreyrou1. Bad Blood: Secrets and Lies in a Silicon Valley Startup
Keynote Speaker: John Carreyrou, Two-Time Pulitzer Prize Winning Journalist and Author
Starting in late 2015, John Carreyrou wrote a series of articles on Theranos, the blood-testing start-up founded by Elizabeth Holmes. The articles questioned the Theronos finger-prick test claims and ultimately exposed Theranos as a fraud, contributing to its downfall. Carreyrou’s new book, Bad Blood: Secrets and Lies in a Silicon Valley Startup, was released earlier this year. A film version is also in the works starring Jennifer Lawrence. Register now to hear John Carreyrou present the full story and answer your questions.

James Carson2. G2 Power Panel: Lab Leaders in Transition
Dr. James Carson, Dr. James R. Jackson, Kamal Patel, Sonny Varadan
The G2 Power Panel brings you the insights and ideas of 4 C-level lab leaders who are successfully guiding their labs through massive transition. They will share their “inside” stories and tactics and explain how they refined their business models, technologies, and competitive strategies to succeed at a time when many labs are struggling just to survive.

James Crawford3. Transitioning from Lab 1.0 to Lab 2.0: What It Means for You; What It Means for Your Stakeholders
Keynote Speaker: Dr. James M. Crawford, Founding Member, Project Santa Fe
“This is your call to be part of the Lab 2.0 Movement” The concept of “Clinical Lab 2.0” was introduced in 2017 by Project Santa Fe, with the goal of establishing the evidence base for valuation of the clinical lab. In this session, lessons learned from ongoing demonstration projects will be shared, with the goal of equipping attendees to transform their own work effort from transactional 1.0 involvement in health care delivery, to a leadership position in driving 2.0 Health Care. This is also your call to help us collectively drive the future success of clinical laboratories

Jack Cochran4. Transforming Health Care in the Information Age
Keynote Speaker: Dr. Jack Cochran, Strategic Advisor, Clarify Health Solutions, Inc.
“We can’t treat our way out of the health care crisis. We must learn our way out of it.” Today, health care is much more complex. In the information age, the evolution of learning and application of big data, analytics, and artificial intelligence is a central reality in the diagnostic laboratory practice. Lab professionals are major contributors to the growth of meaningful data and information and are adding to the volumes of existing data. This information must be available to patients, physicians, and care teams, along with the technology and tools to understand and use the data. In this keynote, Dr. Cochran will explore how health care must transform to meet the challenges of the information age and to address the crisis of affordability and value in health care. Dr. Cochran is a Stanford-trained surgeon and served as executive director (CEO) of the Permanente Federation at Kaiser Permanente from 2007 to 2014. He is also the author of the upcoming book, Healer, Leader, Partner, and will conduct a book-signing after his presentation.

David Humphreys5. Elevating the Clinical Laboratory’s Role in Healthcare
Keynote Speaker: David Humphreys, Head of Health Policy & Clinical Evidence Practice, Economist Intelligence Unit
The movement towards value-based healthcare provides a platform for a better future for all involved in the health ecosystem. However, despite its core value principles of data, timely and efficient diagnosis, and patient centricity, the lab has been relegated to near commodity status. This is indicative of a fragmented value chain that under-exploits sources in decision-making at a time when the health world’s stated focus is on outcomes. This session will present the key results from the Economist Intelligence Unit’s (EIU) study aimed at identifying an actionable, achievable path for the lab to play an elevated role in healthcare, including the reality of the clinical lab today, the influence of stakeholder perception and actions on current dynamics, and the specific initiatives that could increase the lab’s impact in the overall patient care pathway.

Lisa Jean Clifford6. Accelerating Diagnosis and Treatment of Cancer Using Digital Pathology
Lisa Jean Clifford, COO & Chief Strategy Officer, Gestalt Diagnostics
Digital pathology is expected to grow rapidly and have an enormous impact upon diagnostic labs. This presentation will discuss accelerating the diagnosis and treatment of cancer using digital pathology to improve efficiencies in workflow, secondary consults, tumor boards, research, training, and much more. Participants will gain a clear understanding of how digital pathology speeds the diagnosis and treatment process for patients, find out how to determine if digital pathology is a good technology for their lab, and know the key areas that digital pathology can help in advancing the pathology workflow process.

Register Now

Loading...

Register Now

Loading...